ArticleDiabetes, obesity & metabolism2018

Long-term safety and efficacy of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes.

Takashi Kadowaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.